Evaxion A (EVAX) Net Income (2020 - 2026)
Evaxion A (EVAX) posted Net Income of -$4.1 million for Q1 2026, up 36.83% quarter-over-quarter from -$6.4 million in Q4 2025, and down 106.77% year-on-year from $60.0 million in Q1 2025.
Evaxion A (EVAX) Net Income (2020 - 2026) Analysis & Trends
Evaxion A (EVAX) has reported Net Income for 7 consecutive years, with -$4.1 million the latest figure, recorded in Q1 2026.
- Net Income for Q1 2026 came in at -$4.1 million, down 106.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.6 million (up 21.81% YoY), and the FY2025 annual result was -$9.5 million, up 21.58% from the prior year.
- Net Income was -$4.1 million for Q1 2026 at Evaxion A, up from -$6.4 million in the prior quarter.
- Over five years, Net Income peaked at $4.1 million in Q3 2025 and troughed at -$7.2 million in Q4 2022.
- Average Net Income over 5 years is -$4.4 million, with a median of -$5.2 million recorded in 2025.
- The widest YoY moves for Net Income: up 292.15% in 2025, down 359.1% in 2025.
- Over 5 years, Net Income stood at -$7.2 million in 2022, then soared by 32.43% to -$4.9 million in 2023, then rose by 14.31% to -$4.2 million in 2024, then slumped by 53.84% to -$6.4 million in 2025, then surged by 36.83% to -$4.1 million in 2026.
- Per Business Quant data, the three most recent Net Income figures were -$4.1 million in Q1 2026, -$6.4 million in Q4 2025, and $4.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | - |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | -14.46 Mn |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 227.36 Mn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 1.03 Bn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | - |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 378.00 Mn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 205.99 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | -453.82 Mn |
| 10 | Evaxion A | 1.33 Bn | 1.33 Bn | - | -4.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.06 Mn |
| Dec 31, 2025 | -6.43 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Dec 31, 2024 | -4.18 Mn |
| Sep 30, 2024 | -2.13 Mn |
| Jun 30, 2024 | -6.60 Mn |
| Dec 31, 2023 | -4.88 Mn |
| Sep 30, 2023 | -6.07 Mn |
| Jun 30, 2023 | -6.13 Mn |
| Sep 30, 2022 | -6.09 Mn |
| Jun 30, 2022 | -5.12 Mn |
| Mar 31, 2022 | -6.29 Mn |
| Jun 30, 2021 | -8.16 Mn |
| Mar 31, 2021 | -4.91 Mn |
| Dec 31, 2020 | -5.28 Mn |
| Sep 30, 2020 | -5.17 Mn |
| Jun 30, 2020 | -4.23 Mn |
| Mar 31, 2020 | -3.46 Mn |